Regeneron Pharmaceuticals REGN Otarmeni Gene Therapy Launch Shifts LongTerm Narrative Amid Pipeline Execution Focus HFROB Highland confirms regular quarterly preferred dividend payouts with no unexpected adjustments this quarter Is Elbit Systems ESLT stock facing investor skepticism Elbit Systems posts 162 EPS beat on firm defense demand